or Try an Advanced Search...

    Technical Analysis for PASG - Passage Bio, Inc.

    Grade Last Price % Change Price Change
    F 0.52 0.25% 0.00
    PASG closed up 6.58 percent on Wednesday, November 20, 2024, on 1.37 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PASG trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.25%
    Lower Bollinger Band Walk Weakness 0.25%
    Wide Bands Range Expansion 0.25%
    Lower Bollinger Band Touch Weakness 0.25%
    Oversold Stochastic Weakness 0.25%
    NR7 Range Contraction 6.85%
    Lower Bollinger Band Walk Weakness 6.85%
    New 52 Week Low Weakness 6.85%
    Wide Bands Range Expansion 6.85%
    Below Lower BB Weakness 6.85%
    Older End-of-Day Signals for PASG ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    Down 1% about 1 hour ago
    Up 2% about 1 hour ago
    Up 1% about 1 hour ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    PASG Chart by TradingView
    Basic chart:

    Profile

    Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Organ Systems Rare Diseases Central Nervous System Disorders Nervous System Disorders Lipid Storage Disorders Monogenic Medicine Products Gm1 Rare Tadataka Yamada

    Is PASG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Passage Bio Achieves Milestones in Gene Therapy Trials
    Nov 13 Passage Bio GAAP EPS of -$0.31 misses by $0.08
    Nov 13 Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
    Nov 6 Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference
    Sep 24 Orbimed Advisors LLC Adjusts Stake in Passage Bio Inc
    Sep 23 Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference
    Sep 19 Orbimed Advisors LLC Reduces Stake in Passage Bio Inc
    Sep 16 Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)
    Aug 6 Passage Bio to Participate in Upcoming Investor Conferences
    Aug 1 Passage Bio gains after licensing deal with GEMMA Bio
    See more PASG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.79
    52 Week Low 0.451
    Average Volume 246,315
    200-Day Moving Average 1.00
    50-Day Moving Average 0.63
    20-Day Moving Average 0.60
    10-Day Moving Average 0.57
    Average True Range 0.07
    RSI (14) 39.39
    ADX 23.19
    +DI 12.43
    -DI 22.98
    Chandelier Exit (Long, 3 ATRs) 0.48
    Chandelier Exit (Short, 3 ATRs) 0.65
    Upper Bollinger Bands 0.72
    Lower Bollinger Band 0.49
    Percent B (%b) 0.12
    BandWidth 38.46
    MACD Line -0.03
    MACD Signal Line -0.02
    MACD Histogram -0.0141
    Fundamentals Value
    Market Cap 28.16 Million
    Num Shares 54.8 Million
    EPS -2.05
    Price-to-Earnings (P/E) Ratio -0.25
    Price-to-Sales 0.00
    Price-to-Book 0.43
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.64
    Resistance 3 (R3) 0.64 0.59 0.62
    Resistance 2 (R2) 0.59 0.56 0.59 0.61
    Resistance 1 (R1) 0.55 0.54 0.57 0.56 0.60
    Pivot Point 0.51 0.51 0.52 0.51 0.51
    Support 1 (S1) 0.47 0.48 0.49 0.47 0.42
    Support 2 (S2) 0.42 0.46 0.43 0.42
    Support 3 (S3) 0.38 0.42 0.41
    Support 4 (S4) 0.39